AIM: Several nicotinic acetylcholine receptor (nAChR) subunits have been engineered as fluorescent protein (FP) fusions and exploited to illuminate features of nAChRs. The aim of this work was to create a FP fusion in the nAChR alpha7 subunit without compromising formation of functional receptors. METHODS: A gene construct was generated to introduce yellow fluorescent protein (YFP), in frame, into the otherwise unaltered, large, second cytoplasmic loop between the third and fourth transmembrane domains of the mouse nAChR alpha7 subunit (alpha7Y). SH-EP1 cells were transfected with mouse nAChR wild type alpha7 subunits (alpha7) or with alpha7Y subunits, alone or with the chaperone protein, hRIC-3. Receptor function was assessed using whole-cell current recording. Receptor expression was measured with (125)I-labeled alpha-bungarotoxin (I-Bgt) binding, laser scanning confocal microscopy, and total internal reflectance fluorescence (TIRF) microscopy. RESULTS: Whole-cell currents revealed that alpha7Y nAChRs and alpha7 nAChRs were functional with comparable EC(50) values for the alpha7 nAChR-selective agonist, choline, and IC(50) values for the alpha7 nAChR-selective antagonist, methyllycaconitine. I-Bgt binding was detected only after co-expression with hRIC-3. Confocal microscopy revealed that alpha7Y had primarily intracellular rather than surface expression. TIRF microscopy confirmed that little alpha7Y localized to the plasma membrane, typical of alpha7 nAChRs. CONCLUSION: nAChRs composed as homooligomers of alpha7Y subunits containing cytoplasmic loop YFP have functional, ligand binding, and trafficking characteristics similar to those of alpha7 nAChRs. alpha7Y nAChRs may be used to elucidate properties of alpha7 nAChRs and to identify and develop novel probes for these receptors, perhaps in high-throughput fashion.
AIM: Several nicotinic acetylcholine receptor (nAChR) subunits have been engineered as fluorescent protein (FP) fusions and exploited to illuminate features of nAChRs. The aim of this work was to create a FP fusion in the nAChR alpha7 subunit without compromising formation of functional receptors. METHODS: A gene construct was generated to introduce yellow fluorescent protein (YFP), in frame, into the otherwise unaltered, large, second cytoplasmic loop between the third and fourth transmembrane domains of the mousenAChR alpha7 subunit (alpha7Y). SH-EP1 cells were transfected with mousenAChR wild type alpha7 subunits (alpha7) or with alpha7Y subunits, alone or with the chaperone protein, hRIC-3. Receptor function was assessed using whole-cell current recording. Receptor expression was measured with (125)I-labeled alpha-bungarotoxin (I-Bgt) binding, laser scanning confocal microscopy, and total internal reflectance fluorescence (TIRF) microscopy. RESULTS: Whole-cell currents revealed that alpha7Y nAChRs and alpha7 nAChRs were functional with comparable EC(50) values for the alpha7 nAChR-selective agonist, choline, and IC(50) values for the alpha7 nAChR-selective antagonist, methyllycaconitine. I-Bgt binding was detected only after co-expression with hRIC-3. Confocal microscopy revealed that alpha7Y had primarily intracellular rather than surface expression. TIRF microscopy confirmed that little alpha7Y localized to the plasma membrane, typical of alpha7 nAChRs. CONCLUSION: nAChRs composed as homooligomers of alpha7Y subunits containing cytoplasmic loop YFP have functional, ligand binding, and trafficking characteristics similar to those of alpha7 nAChRs. alpha7Y nAChRs may be used to elucidate properties of alpha7 nAChRs and to identify and develop novel probes for these receptors, perhaps in high-throughput fashion.
Authors: Eleonora Palma; Anna M Mileo; Ataulfo Martinez-Torres; Fabrizio Eusebi; Ricardo Miledi Journal: Proc Natl Acad Sci U S A Date: 2002-03-12 Impact factor: 11.205
Authors: Serguei S Khiroug; Patricia C Harkness; Patricia W Lamb; Sterling N Sudweeks; Leonard Khiroug; Neil S Millar; Jerrel L Yakel Journal: J Physiol Date: 2002-04-15 Impact factor: 5.182
Authors: Luis M Valor; José Mulet; Francisco Sala; Salvador Sala; Juan J Ballesta; Manuel Criado Journal: Biochemistry Date: 2002-06-25 Impact factor: 3.162
Authors: Teresa A Murray; Daniel Bertrand; Roger L Papke; Andrew A George; Rigo Pantoja; Rahul Srinivasan; Qiang Liu; Jie Wu; Paul Whiteaker; Henry A Lester; Ronald J Lukas Journal: Mol Pharmacol Date: 2011-10-28 Impact factor: 4.436
Authors: Caroline Ray; Erik J Soderblom; Yushi Bai; F Ivy Carroll; Marc G Caron; Larry S Barak Journal: ACS Chem Biol Date: 2017-01-24 Impact factor: 5.100
Authors: Seon A Lee; Kevin S Holly; Vladislav Voziyanov; Stephanie L Villalba; Rudi Tong; Holly E Grigsby; Edward Glasscock; Francis G Szele; Ioannis Vlachos; Teresa A Murray Journal: PLoS One Date: 2016-01-22 Impact factor: 3.240